New therapies for hepatitis delta virus infection

Hepatitis delta virus (HDV) infection is a defective virus requiring hepatitis B virus (HBV) for its complete replication cycle. HDV is a small hepatotropic RNA virus and around 15 to 25 million people worldwide are living with chronic hepatitis delta (CHD) infection. However, the prevalence of HDV...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2021-06, Vol.41 (S1), p.30-37
Hauptverfasser:	Loureiro, Dimitri, Castelnau, Corinne, Tout, Issam, Boyer, Nathalie, Narguet, Stéphanie, Menasria Benazzouz, Sabrina, Louis, Zeina, Pons‐Kerjean, Nathalie, Giuly, Nathalie, Marcellin, Patrick, Mansouri, Abdellah, Asselah, Tarik, Valenti, Luca
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Africa, Western Antiviral Agents - therapeutic use Carcinoma, Hepatocellular - drug therapy Chronic infection Cirrhosis direct‐acting antivirals Dosage entry inhibitor Europe Health services Hepatitis Hepatitis B Hepatitis B - drug therapy Hepatitis B surface antigen Hepatitis B virus Hepatitis Delta Virus Hepatocellular carcinoma Humans Immunomodulation Immunomodulators Infections Inhibitors Interferon interferons Liver diseases Liver Neoplasms - drug therapy Nucleic acids Polymers prenylation inhibitors River basins RNA viruses South America Superinfection Vaccines Viremia Viruses α-Interferon
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!